Compound ID | 597
Class: Macrolide (15-membered macrolide, ketolide)
| Spectrum of activity: | Gram-positive |
| Description: | Synthetic compound, derived from 15-methylerythromycin A |
| Institute where first reported: | Johnson & Johnson Pharmaceutical |
| Year first mentioned: | 2002 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Likely to be due to the failure of Ketek (Telithromycin)- (LS) |
| External links: | |
| Citations: |
|